Femto-LASIK outperformed

Article

Moria's new microkeratome, One Use-Plus SBK, outperforms Femto-LASIK, it was announced at this year's meeting of the American Society of Cataract and Refractive Surgery (ASCRS).

Moria's new microkeratome, One Use-Plus SBK, outperforms Femto-LASIK, it was announced at this year's meeting of the American Society of Cataract and Refractive Surgery (ASCRS).

Richard J. Duffey, MD of Premier Medical Eye Group, Alabama, US compared flap thickness predictability, speed of visual recovery, higher order aberrations, smoothness of stromal bed and patient comfort between the two techniques. Dr Duffey has no financial interest in Moria or the One Use-Plus SBK.

For every variable, the One Use-Plus compared equally or favourably with Femto-LASIK, with none of the associated complications of the latter device. Postoperative pain in the first one to five hours was lower in both frequency and intensity when using the One Use-Plus than with Femto-LASIK.

Dr Duffey concluded that the One Use-Plus was a better option for both patients and surgeons than Femto-LASIK.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.